Le Lézard
Classified in: Health
Subjects: CCA, FVT

BD to Announce Financial Results for its Second Quarter of Fiscal 2024


FRANKLIN LAKES, N.J., April 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2024 on Thursday, May 2, 2024. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's second quarter of fiscal year 2024, which ended on March 31, 2024.

BD management will host an audio webcast at 8 a.m. ET on May 2, 2024 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

Contacts:




Media:

Investors:

Troy Kirkpatrick

Adam Reiffe

VP, Public Relations

Sr. Director, Investor Relations

858.617.2361

201.847.6927        

[email protected]

[email protected]     

 

SOURCE BD (Becton, Dickinson and Company)


These press releases may also interest you

at 22:55
The Company demonstrated a deep commitment to achieving ESG success in partnership with global clients, creating long-term value for all stakeholders.The Company made remarkable progress in tackling climate change, achieving a 29% intensity reduction...

at 22:39
On April 25, 2024, Waterdrop Inc. ("Waterdrop", the "Company" or "we") , a leading technology platform dedicated to insurance and healthcare service with a positive social impact, released its annual report on Form 20-F for the fiscal year ending...

at 22:36
Yesterday, The Kids Mental Health Foundation (KMHF),...

at 21:03
The Healthcare Asia Awards, a prestigious international recognition program, honors exceptional healthcare institutions across Asia for their pioneering achievements in healthcare innovation and patient care. On March 26th, at the 2024 Awards...

at 21:00
2023 Adjusted Revenue1 record revenue of $17.05 million, an increase of 102% compared to 2022.2023 GAAP revenue was $11.51 million an increase of 170% compared to 2022. 2023 gross margin of 43.11% compared to 43.00% in 2022.Q4, 2023 Adjusted Revenue1...

at 20:47
MemorialCare announced today that they have renewed their partnership with the Los Angeles Angels. In addition, Miller Children's & Women's Hospital Long Beach will continue as the official children's hospital of Angels Baseball. Angels Catcher...



News published on and distributed by: